SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Filing Date
Mar 12, 2018
Document Date
Dec 31, 2017
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.